RSS

Reaction Biology

Contract research organisation (CRO), Reaction Biology, has partnered with an open science drug discovery and development company, M4K Pharma, in the fight against diffuse intrinsic pontine glioma (DIPG) — a rare paediatric brain cancer. Read more

Opinion